Literature DB >> 27005309

CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats.

Emily E Thompson1, Julia E Jagielo-Miller1, V Kiran Vemuri2, Alexandros Makriyannis2, Peter J McLaughlin3.   

Abstract

Cannabinoid CB1 antagonists are widely known to reduce motivation for food, but it is not known whether they induce satiety or reduce reward value of food. It may therefore be necessary to compare effects of altered satiety and reward food value in the same appetitive task, and determine whether CB1 antagonism produces a behavior pattern similar to either, both, or neither. A fine-grained analysis of fixed-ratio 10 (FR10) responding for palatable food initially included number and duration of, and between, all lever presses and food tray entries in order to differentiate the pattern of suppression of prefeeding from that caused by reducing the reward value of the pellets with quinine. Discriminant function analysis then determined that these manipulations were best differentiated by effects on tray entries, pellet retrieval latencies, and time of the first response. At 0.5 mg/kg, AM 6527 produced similar effects to reducing reward value, but at 1.0 and 4.0 mg/kg, effects were more similar to those when animals were satiated. We conclude that AM 6527 both reduced reward value and enhanced satiety, but as dose increased, effects on satiety became much more prominent. These findings contribute to knowledge about the behavioral processes affected by CB1 antagonism.
© The Author(s) 2016.

Entities:  

Keywords:  Cannabinoid; motivation; multivariate analysis; obesity; reward

Mesh:

Substances:

Year:  2016        PMID: 27005309      PMCID: PMC5531753          DOI: 10.1177/0269881116639287

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  56 in total

1.  SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.

Authors:  J Simiand; M Keane; P E Keane; P Soubrié
Journal:  Behav Pharmacol       Date:  1998-03       Impact factor: 2.293

2.  Palatability, food intake and the behavioural satiety sequence in male rats.

Authors:  Y Ishii; J E Blundell; J C G Halford; R J Rodgers
Journal:  Physiol Behav       Date:  2003-10

Review 3.  How many sites of action for endocannabinoids to control energy metabolism?

Authors:  U Pagotto; C Cervino; V Vicennati; G Marsicano; B Lutz; R Pasquali
Journal:  Int J Obes (Lond)       Date:  2006-04       Impact factor: 5.095

4.  Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB₁ receptor blockade.

Authors:  Luigi Bellocchio; Edgar Soria-Gómez; Carmelo Quarta; Mathilde Metna-Laurent; Pierre Cardinal; Elke Binder; Astrid Cannich; Anna Delamarre; Martin Häring; Mar Martín-Fontecha; David Vega; Thierry Leste-Lasserre; Dusan Bartsch; Krisztina Monory; Beat Lutz; Francis Chaouloff; Uberto Pagotto; Manuel Guzman; Daniela Cota; Giovanni Marsicano
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

5.  Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists.

Authors:  P J McLaughlin; K M Winston; L A Swezey; V K Vemuri; A Makriyannis; J D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2010-04-18       Impact factor: 3.533

6.  Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

Authors:  André J Scheen; Nick Finer; Priscilla Hollander; Michael D Jensen; Luc F Van Gaal
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

7.  CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats.

Authors:  Kiri L Wills; Kiran Vemuri; Alana Kalmar; Alan Lee; Cheryl L Limebeer; Alexandros Makriyannis; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2014-04-27       Impact factor: 4.530

8.  Reduced sensitivity to reward in CB1 knockout mice.

Authors:  Carles Sanchis-Segura; Brandon H Cline; Giovanni Marsicano; Beat Lutz; Rainer Spanagel
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

9.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

Authors:  Daniela Cota; Giovanni Marsicano; Matthias Tschöp; Yvonne Grübler; Cornelia Flachskamm; Mirjam Schubert; Dorothee Auer; Alexander Yassouridis; Christa Thöne-Reineke; Sylvia Ortmann; Federica Tomassoni; Cristina Cervino; Enzo Nisoli; Astrid C E Linthorst; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

10.  Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule.

Authors:  Todd M Hillhouse; Joseph H Porter
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

View more
  6 in total

1.  Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor.

Authors:  Peter J McLaughlin; Julia E Jagielo-Miller; Emily S Plyler; Kerry K Schutte; V Kiran Vemuri; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2017-02-01       Impact factor: 4.530

Review 2.  Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?

Authors:  Jürg Gertsch
Journal:  Br J Pharmacol       Date:  2017-01-16       Impact factor: 8.739

Review 3.  Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling.

Authors:  J M Wenzel; J F Cheer
Journal:  Neuropsychopharmacology       Date:  2017-06-27       Impact factor: 7.853

Review 4.  The Endocannabinoid System and Eating Behaviours: a Review of the Current State of the Evidence.

Authors:  Nathaly Aguilera Vasquez; Daiva E Nielsen
Journal:  Curr Nutr Rep       Date:  2022-08-18

5.  Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin.

Authors:  Bárbara S Pinheiro; Cristina Lemos; Fernanda Neutzling Kaufmann; Joana M Marques; Carla S da Silva-Santos; Eugénia Carvalho; Ken Mackie; Ricardo J Rodrigues; Rodrigo A Cunha; Attila Köfalvi
Journal:  Brain Res Bull       Date:  2016-05-18       Impact factor: 4.077

6.  "Photo-Rimonabant": Synthesis and Biological Evaluation of Novel Photoswitchable Molecules Derived from Rimonabant Lead to a Highly Selective and Nanomolar "Cis-On" CB1R Antagonist.

Authors:  Diego A Rodríguez-Soacha; Julia Fender; Yesid A Ramírez; Juan Antonio Collado; Eduardo Muñoz; Rangan Maitra; Christoph Sotriffer; Kristina Lorenz; Michael Decker
Journal:  ACS Chem Neurosci       Date:  2021-04-15       Impact factor: 5.780

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.